{"content":"<li class=\"n-box-item date-title\" data-end=\"1561780799\" data-start=\"1561694400\" data-txt=\"Monday, December 23, 2019\">Friday, June 28, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3474784\" data-ts=\"1561759737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INPX\" target=\"_blank\">INPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474784-inpixonminus-3_7-after-15m-registration-filing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inpixon -3.7% after $15M registration filing</a></h4><ul>   <li>Inpixon (NASDAQ:<a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a>) is <font color=\"red\">3.7% lower</font> after hours following a <a href=\"https://seekingalpha.com/filing/4550165\" target=\"_blank\">registration</a> to offer $15M in shares and warrants.</li>    <li>Purchasers who would surpass 4.99% ownership are also being offered the chance instead to purchase pre-funded warrants at a $0.01 exercise price.</li>    <li>Net proceeds would go toward working capital and other general purposes (including research and development, sales and marketing and the satisfaction of outstanding amounts payable to our vendors in connection with trade payables).</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3474784\" data-linked=\"Inpixon -3.7% after $15M registration filing\" data-tweet=\"$INPX - Inpixon -3.7% after $15M registration filing https://seekingalpha.com/news/3474784-inpixonminus-3_7-after-15m-registration-filing?source=tweet\" data-url=\"https://seekingalpha.com/news/3474784-inpixonminus-3_7-after-15m-registration-filing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474781\" data-ts=\"1561758585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474781-ag-wpx-heb-and-keg-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AG, WPX, HEB and KEG among notable after hour movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/RTRX' title='Retrophin, Inc.'>RTRX</a> <font color=\"green\">+6%</font>. <a href='https://seekingalpha.com/symbol/HEB' title='Hemispherx Biopharma, Inc.'>HEB</a> <font color=\"green\">+3.6%</font>. <a href='https://seekingalpha.com/symbol/SHLO' title='Shiloh Industries, Inc.'>SHLO</a> <font color=\"green\">+2.7%</font>. <a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a> <font color=\"green\">+2.2%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/AQXP' title='Aquinox Pharmaceuticals, Inc.'>AQXP</a> <font color=\"red\">-3.4%</font>. <a href='https://seekingalpha.com/symbol/WPX' title='WPX Energy, Inc.'>WPX</a> <font color=\"red\">-2.7%</font>. <a href='https://seekingalpha.com/symbol/AG' title='First Majestic Silver Corp.'>AG</a> <font color=\"red\">-2%</font>. <a href='https://seekingalpha.com/symbol/BRT' title='BRT Apartments Corp.'>BRT</a> <font color=\"red\">-1.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474781\" data-linked=\"AG, WPX, HEB and KEG among notable after hour movers\" data-tweet=\"$RTRX $AIM $SHLO - AG, WPX, HEB and KEG among notable after hour movers https://seekingalpha.com/news/3474781-ag-wpx-heb-and-keg-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474781-ag-wpx-heb-and-keg-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474769\" data-ts=\"1561754870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474769-ung-ugaz-dgaz-jo-and-soxl-among-weekly-etf-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UNG, UGAZ, DGAZ, JO and SOXL among weekly ETF movers</a></h4><ul><li><strong>Gainers: </strong>Natural Gas 3X Long ETN Velocityshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>) <font color=\"green\">+19.4%</font>. Ultra DJ-UBS Natural Gas Proshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>) <font color=\"green\">+13.0%</font>. Semiconductor Bull 3X Direxion (NYSEARCA:<a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>) <font color=\"green\">+10.6%</font>. Ipatha.B Coffee Subindex TR ETN (NYSEARCA:<a href='https://seekingalpha.com/symbol/JO' title='iPath Series B Bloomberg Coffee Subindex Total Return ETN'>JO</a>) <font color=\"green\">+9.3%</font>. Direxion Regional Banks Bull 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/DPST' title='Direxion Daily Regional Banks Bull 3x Shares ETF'>DPST</a>) <font color=\"green\">+7.9%</font>.</li><li><strong>Losers: </strong>Natural Gas -3X Inverse ETN Velocityshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>) <font color=\"red\">-19.1%</font>. Ultrashort Natural Gas Proshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>) <font color=\"red\">-12.7%</font>. Semiconductor Bear 3X Direxion (NYSEARCA:<a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>) <font color=\"red\">-10.9%</font>. Ultrashort Semiconductors Proshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>) <font color=\"red\">-7.8%</font>. Direxion Daily Utilities Bull 3X Shares (NYSEARCA:<a href='https://seekingalpha.com/symbol/UTSL' title='Direxion Daily Utilities Bull 3X ETF'>UTSL</a>) <font color=\"red\">-7.7%</font>.</li><li><strong>Top non-leveraged gainers: </strong>3D Printing ETF  (NYSE:<a href='https://seekingalpha.com/symbol/PRNT' title='3D Printing ETF'>PRNT</a>) <font color=\"green\">+6.6%</font>. US Natural Gas Fund (NYSEARCA:<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>) <font color=\"green\">+6.4%</font>. Ark Genomic Revolution Multi-Sector ETF  (NYSEARCA:<a href='https://seekingalpha.com/symbol/ARKG' title='ARK Genomic Revolution Multi-Sector ETF'>ARKG</a>) <font color=\"green\">+5.6%</font>. Ark Innovation ETF  (NYSEARCA:<a href='https://seekingalpha.com/symbol/ARKK' title='ARK Innovation ETF'>ARKK</a>) <font color=\"green\">+5.6%</font>. Ark Industrial Innovation ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/ARKQ' title='ARK Industrial Innovation ETF'>ARKQ</a>)<font color=\"green\"> +4.1%</font>.</li><li><strong>Top non-leveraged losers: </strong>G-X MSCI Pakistan ETF  (NYSEARCA:<a href='https://seekingalpha.com/symbol/PAK' title='Global X MSCI Pakistan ETF'>PAK</a>) <font color=\"red\">-7.1%</font>. Global Ex-US Real Estate Wisdomtree (NYSEARCA:<a href='https://seekingalpha.com/symbol/DRW' title='WisdomTree Global ex-US Real Estate ETF'>DRW</a>) <font color=\"red\">-4.6%</font>. Wisdomtree Middle East Dividend Fund  (NASDAQ:<a href='https://seekingalpha.com/symbol/GULF' title='WisdomTree Middle East Dividend ETF'>GULF</a>) <font color=\"red\">-3.7%</font>. JH Utilities Multifactor ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/JHMU' title='John Hancock Multifactor Utilities ETF'>JHMU</a>) <font color=\"red\">-3.6%</font>. G-X Norway ETF  (NYSEARCA:<a href='https://seekingalpha.com/symbol/NORW' title='Global X MSCI Norway ETF'>NORW</a>) <font color=\"red\">-3.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474769\" data-linked=\"UNG, UGAZ, DGAZ, JO and SOXL among weekly ETF movers\" data-tweet=\"$UGAZ $BOIL $SOXL - UNG, UGAZ, DGAZ, JO and SOXL among weekly ETF movers https://seekingalpha.com/news/3474769-ung-ugaz-dgaz-jo-and-soxl-among-weekly-etf-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474769-ung-ugaz-dgaz-jo-and-soxl-among-weekly-etf-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474766\" data-ts=\"1561754432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RTRX\" target=\"_blank\">RTRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474766-fda-oks-retrophins-thiola-for-cystinuria-shares-up-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Retrophin&#39;s Thiola for cystinuria; shares up 3% after hours</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17559623-retrophin-announces-fda-approval-thiola-ec-tiopronin-100mg-300mg-tablets-treatment-cystinuria\" target=\"_blank\">approves </a>Retrophin's (NASDAQ:<a href='https://seekingalpha.com/symbol/RTRX' title='Retrophin, Inc.'>RTRX</a>) enteric coated Thiola EC (tiopronin) for the treatment of a rare inherited disorder called <a href=\"https://ghr.nlm.nih.gov/condition/cystinuria\" target=\"_blank\">cystinuria </a>(high levels of the amino acid cysteine in the urine) that leads to kidney stones.</li><li>Commercial launch will commence in July.</li><li>Shares are up <font color=\"green\">3%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474766\" data-linked=\"FDA OKs Retrophin&#39;s Thiola for cystinuria; shares up 3% after hours\" data-tweet=\"$RTRX - FDA OKs Retrophin&#39;s Thiola for cystinuria; shares up 3% after hours https://seekingalpha.com/news/3474766-fda-oks-retrophins-thiola-for-cystinuria-shares-up-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3474766-fda-oks-retrophins-thiola-for-cystinuria-shares-up-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474759\" data-ts=\"1561753781\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIFE\" target=\"_blank\">LIFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474759-atyr-pharma-reverse-splits-stock-1-14-shares-down-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ATyr Pharma reverse splits stock 1:14; shares down 4% after hours</a></h4><ul><li>Aimed at regaining compliance with Nasdaq's minimum bid price listing requirement, aTyr Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/LIFE' title='aTyr Pharma, Inc.'>LIFE</a>) will execute a <a href=\"https://seekingalpha.com/pr/17559555-atyr-pharma-announces-reverse-stock-split-regain-nasdaq-compliance\" target=\"_blank\">1:14 reverse split</a> of its common stock after the close today.</li><li>Post-split trading will commence on Monday, July 1.</li><li>Shares are off <font color=\"red\">4%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474759\" data-linked=\"ATyr Pharma reverse splits stock 1:14; shares down 4% after hours\" data-tweet=\"$LIFE - ATyr Pharma reverse splits stock 1:14; shares down 4% after hours https://seekingalpha.com/news/3474759-atyr-pharma-reverse-splits-stock-1-14-shares-down-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3474759-atyr-pharma-reverse-splits-stock-1-14-shares-down-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474745\" data-ts=\"1561752743\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLRX\" target=\"_blank\">BLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474745-biolinerx-reverse-splits-adss-1-15-shares-off-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioLineRx reverse splits ADSs 1:15; shares off 3% after hours</a></h4><ul><li>The board of BioLineRx (NASDAQ:<a href='https://seekingalpha.com/symbol/BLRX' title='BioLineRx Ltd.'>BLRX</a>) has <a href=\"https://seekingalpha.com/pr/17559532-biolinerx-announces-change-ratio-american-depositary-shares-ordinary-shares\" target=\"_blank\">approved a change</a> in its ADS/ordinary share ratio from 1:1 to 1:15, in essence, a reverse split of the ADSs.</li><li>The adjusted ADSs will begin trading on Monday, July 15.</li><li>Shares are down <font color=\"red\">3%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474745\" data-linked=\"BioLineRx reverse splits ADSs 1:15; shares off 3% after hours\" data-tweet=\"$BLRX - BioLineRx reverse splits ADSs 1:15; shares off 3% after hours https://seekingalpha.com/news/3474745-biolinerx-reverse-splits-adss-1-15-shares-off-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3474745-biolinerx-reverse-splits-adss-1-15-shares-off-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474732\" data-ts=\"1561749477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORN\" target=\"_blank\">CORN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474732-corn-plunges-after-bearish-usda-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corn plunges after bearish USDA report</a></h4><ul><li>Bloated longs are on the wrong side of the trade today after <a href=\"https://www.usda.gov/media/agency-reports\" target=\"_blank\">the USDA's latest numbers </a>show 91.7M acres planted to corn vs. trade expectations of just 86.7M.</li><li>The corn plantings have at least some scratching their head, as they're not squaring with what's being seen in the field. The USDA plans to re-interview farmers in 14 states.</li><li>The soybean numbers were a bit more bullish, with 80M acres planted vs. 89M a year ago.</li><li>Corn is <font color=\"red\">down 4.3%</font>, and Beans are <font color=\"green\">up 1.3%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/CORN' title='Teucrium Corn ETF'>CORN</a>, <a href='https://seekingalpha.com/symbol/WEAT' title='Teucrium Wheat Fund'>WEAT</a>, <a href='https://seekingalpha.com/symbol/SOYB' title='Teucrium Soybean Fund'>SOYB</a>, <a href='https://seekingalpha.com/symbol/JJGTF' title='iPath Bloomberg Grains Subindex Total Return ETN'>OTCPK:JJGTF</a>, <a href='https://seekingalpha.com/symbol/GRU' title='ELEMENTS MLCX Grains Index Total Return ETN'>GRU</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3474732\" data-linked=\"Corn plunges after bearish USDA report\" data-tweet=\"$CORN $WEAT $SOYB - Corn plunges after bearish USDA report https://seekingalpha.com/news/3474732-corn-plunges-after-bearish-usda-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3474732-corn-plunges-after-bearish-usda-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474729\" data-ts=\"1561747546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AJRD\" target=\"_blank\">AJRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474729-aerojet-rocketdyne-soaring-buy-canaccord-genuity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aerojet Rocketdyne a soaring Buy at Canaccord Genuity</a></h4><ul><li>Aerojet Rocketdyne (<a href='https://seekingalpha.com/symbol/AJRD' title='Aerojet Rocketdyne Holdings, Inc.'>AJRD</a> <font color=\"green\">+3.2%</font>) is <a href=\"https://www.streetinsider.com/New+Coverage/Canaccord+Genuity+Starts+Aeroject+Rocketdyne+Holdings+%28AJRD%29+at+Buy/15656846.html\" target=\"_blank\">initiated with a Buy rating</a> and $50 price target at Canaccord Genuity, which says the company is well positioned to benefit from several near-term opportunities in the areas of missile defense, hypersonics and space access applications.</li><li>Also, while much of AJRD's cost improvement efforts are reflected in current margins, Canaccord believes a continued focus on the cost structure will provide a tailwind.</li><li>Finally, the firm thinks shares will benefit as the defense outlook remains positive, there is a scarcity premium on small-cap defense stocks, and the company benefits from significant balance sheet flexibility.</li><li>AJRD's average <a href=\"https://seekingalpha.com/symbol/AJRD/ratings/sell-side-ratings\" target=\"_blank\">Selling Side Rating</a> is Outperform, its <a href=\"https://seekingalpha.com/symbol/AJRD/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> is Bullish and its <a href=\"https://seekingalpha.com/symbol/AJRD/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Very Bullish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474729\" data-linked=\"Aerojet Rocketdyne a soaring Buy at Canaccord Genuity\" data-tweet=\"$AJRD - Aerojet Rocketdyne a soaring Buy at Canaccord Genuity https://seekingalpha.com/news/3474729-aerojet-rocketdyne-soaring-buy-canaccord-genuity?source=tweet\" data-url=\"https://seekingalpha.com/news/3474729-aerojet-rocketdyne-soaring-buy-canaccord-genuity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474728\" data-ts=\"1561747443\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474728-ssys-gtt-and-sy-among-notable-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SSYS, GTT and SY among notable tech movers</a></h4><ul><li><strong>Gainers: </strong>Foresight Autonomous Holdings(NASDAQ:<a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a>) <font color=\"green\">+47%</font>. Phunware (NASDAQ:<a href='https://seekingalpha.com/symbol/PHUN' title='Phunware, Inc.'>PHUN</a>) <font color=\"green\">+23%</font>. CalAmp (NASDAQ:<a href='https://seekingalpha.com/symbol/CAMP' title='CalAmp Corp.'>CAMP</a>) <font color=\"green\">+16%</font>. Jiayin Group (NASDAQ:<a href='https://seekingalpha.com/symbol/JFIN' title='Jiayin Group Inc.'>JFIN</a>) <font color=\"green\">+13%</font>. Stratasys (NASDAQ:<a href='https://seekingalpha.com/symbol/SSYS' title='Stratasys Ltd.'>SSYS</a>) <font color=\"green\">+13%</font>.</li> <li><strong>Losers: </strong>Phoenix New Media (NYSE:<a href='https://seekingalpha.com/symbol/FENG' title='Phoenix New Media Limited'>FENG</a>) <font color=\"red\">-11%</font>. GTT Communications (NYSE:<a href='https://seekingalpha.com/symbol/GTT' title='GTT Communications, Inc.'>GTT</a>) <font color=\"red\">-10%</font>. So-Young International (NASDAQ:<a href='https://seekingalpha.com/symbol/SY' title='So-Young International Inc.'>SY</a>) <font color=\"red\">-6%</font>. HC2 Holdings (NYSE:<a href='https://seekingalpha.com/symbol/HCHC' title='HC2 Holdings, Inc.'>HCHC</a>) <font color=\"red\">-7%</font>. Jianpu Technology (NYSE:<a href='https://seekingalpha.com/symbol/JT' title='Jianpu Technology Inc.'>JT</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474728\" data-linked=\"SSYS, GTT and SY among notable tech movers\" data-tweet=\"$FRSX $PHUN $CAMP - SSYS, GTT and SY among notable tech movers https://seekingalpha.com/news/3474728-ssys-gtt-and-sy-among-notable-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474728-ssys-gtt-and-sy-among-notable-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474726\" data-ts=\"1561746842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GD\" target=\"_blank\">GD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474726-general-dynamics-secures-faa-certification-for-newest-g600-jet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">General Dynamics secures FAA certification for newest G600 jet</a></h4><ul><li>General Dynamics (<a href='https://seekingalpha.com/symbol/GD' title='General Dynamics Corporation'>GD</a> <font color='green'>+1.9%</font>) says its new Gulfstream G600 luxury jet <a href=\"https://seekingalpha.com/pr/17559376-general-dynamics-announces-gulfstream-g600-granted-faa-certification\" target=\"_blank\">won type and  production certificates</a> from the Federal Aviation Administration, clearing the way for the first completed G600  deliveries to customers as scheduled this year.</li><li>\"Getting both authorizations on the same day is evidence of the maturity  of our G600 production processes and speaks to the safety and  reliability of the aircraft's design,\" says Gulfstream president Mark Burns.</li><li>GD's Gulfstream G500 earned its type and production certificates simultaneously just a year ago.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474726\" data-linked=\"General Dynamics secures FAA certification for newest G600 jet\" data-tweet=\"$GD - General Dynamics secures FAA certification for newest G600 jet https://seekingalpha.com/news/3474726-general-dynamics-secures-faa-certification-for-newest-g600-jet?source=tweet\" data-url=\"https://seekingalpha.com/news/3474726-general-dynamics-secures-faa-certification-for-newest-g600-jet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474724\" data-ts=\"1561745766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474724-chesapeake-energy-finds-bullish-support-fromt-morgan-stanley-analyst\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chesapeake Energy finds bullish support fromt Morgan Stanley analyst</a></h4><ul><li>Chesapeake Energy (<a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color='green'>+2.9%</font>) moves higher after Morgan Stanley analyst Devin McDermott resumes coverage of the stock with an <a href=\"https://www.barrons.com/articles/chesapeake-energy-stock-could-rebound-as-debt-falls-analyst-says-51561742109\" target=\"_blank\">Overweight rating</a> and $2.75 price target, believing the company is in good shape to pay down its substantial debt load and benefit from asset sales.</li><li>McDermott says he now see a clearer path toward lower leverage and that his recent time with management pointed toward solid execution on operational improvements.</li><li>CHK's average <a href=\"https://seekingalpha.com/symbol/CHK/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Hold, its <a href=\"https://seekingalpha.com/symbol/CHK/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> is Bullish, and its <a href=\"https://seekingalpha.com/symbol/CHK/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Bearish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474724\" data-linked=\"Chesapeake Energy finds bullish support fromt Morgan Stanley analyst\" data-tweet=\"$CHK - Chesapeake Energy finds bullish support fromt Morgan Stanley analyst https://seekingalpha.com/news/3474724-chesapeake-energy-finds-bullish-support-fromt-morgan-stanley-analyst?source=tweet\" data-url=\"https://seekingalpha.com/news/3474724-chesapeake-energy-finds-bullish-support-fromt-morgan-stanley-analyst\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474722\" data-ts=\"1561745405\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VUZI\" target=\"_blank\">VUZI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474722-vuzix-files-patent-for-new-ar-glasses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vuzix files patent for new AR glasses</a></h4><ul><li>Vuzix (NASDAQ:<a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corporation'>VUZI</a>) <a href=\"https://seekingalpha.com/pr/17559449-vuzix-files-patent-next-generation-waveguide-based-ar-smart-glasses\" target=\"_blank\">announces</a> filing a patent with the U.S. Patent &amp; Trademark Office on next-gen waveguide-based AR smart glasses that are already in development.</li><li>Earlier this week, Vuzix gave <a href=\"https://next.reality.news/news/vuzix-confirms-new-smaller-smartglasses-model-with-fashion-friendly-design-0199666/\" target=\"_blank\"><em>New Reality</em></a> a look at the forthcoming glasses, which pack the best of VUZI's tech in a streamlined frame that isn't significantly thicker than regular glasses.</li><li>VUZI shares are <font color=\"red\">down 4.1% </font>to $4.10.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474722\" data-linked=\"Vuzix files patent for new AR glasses\" data-tweet=\"$VUZI - Vuzix files patent for new AR glasses https://seekingalpha.com/news/3474722-vuzix-files-patent-for-new-ar-glasses?source=tweet\" data-url=\"https://seekingalpha.com/news/3474722-vuzix-files-patent-for-new-ar-glasses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474721\" data-ts=\"1561745345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RMHB\" target=\"_blank\">RMHB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474721-rocky-mountain-high-brands-updates-on-lipari\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rocky Mountain High Brands updates on Lipari</a></h4><ul> <li>Rocky Mountain High Brands (<a href='https://seekingalpha.com/symbol/RMHB' title='Rocky Mountain High Brands, Inc.'>OTCQB:RMHB</a> <font color='red'>-10.1%</font>) issues a clarification on regarding Sweet Rock and Lipari Foods. (\u201cLipari\u201d).</li>   <li>It's noted that Lipari does not currently distribute foods containing hemp-derived CBD. Instead, Lipari's current policy regarding hemp is to distribute foods only containing hemp seed-derived ingredients.</li>  <li>\"As the public is aware, federal and state laws are rapidly improving regarding clarification of hemp-derived products. The FDA is determining how to regulate hemp-derived products infused into foods. We anticipate the FDA to publish directives regarding the manufacturing, distribution and sale of hemp-derived products,\" state Rocky Mountain High CEO Michael Welch.</li>  <li>Welch represents Rocky Mountain High Brands as a board member on the U.S Hemp Roundtable.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17559462-rocky-mountain-high-brands-announces-clarification-regarding-lipari-foods\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3474721\" data-linked=\"Rocky Mountain High Brands updates on Lipari\" data-tweet=\"$RMHB - Rocky Mountain High Brands updates on Lipari https://seekingalpha.com/news/3474721-rocky-mountain-high-brands-updates-on-lipari?source=tweet\" data-url=\"https://seekingalpha.com/news/3474721-rocky-mountain-high-brands-updates-on-lipari\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474719\" data-ts=\"1561745213\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474719-geospace-technologies-and-eqt-among-energy-materials-gainers-only-pedevco-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Geospace Technologies and EQT among Energy/Materials gainers; only PEDEVCO among losers</a></h4><ul><li><b>Gainers: </b>Geospace Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/GEOS' title='Geospace Technologies Corporation'>GEOS</a>) <font color=\"green\">+12%</font>. EQT (NYSE:<a href='https://seekingalpha.com/symbol/EQT' title='EQT Corporation'>EQT</a>) <font color=\"green\">+10%</font>. LSB Industries (NYSE:<a href='https://seekingalpha.com/symbol/LXU' title='LSB Industries, Inc.'>LXU</a>) <font color=\"green\">+9%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"green\">+9%</font>. Chaparral Energy (NYSE:<a href='https://seekingalpha.com/symbol/CHAP' title='Chaparral Energy, Inc.'>CHAP</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>PEDEVCO (NYSEMKT:<a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474719\" data-linked=\"Geospace Technologies and EQT among Energy/Materials gainers; only PEDEVCO among losers\" data-tweet=\"$GEOS $EQT $LXU - Geospace Technologies and EQT among Energy/Materials gainers; only PEDEVCO among losers https://seekingalpha.com/news/3474719-geospace-technologies-and-eqt-among-energy-materials-gainers-only-pedevco-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474719-geospace-technologies-and-eqt-among-energy-materials-gainers-only-pedevco-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474712\" data-ts=\"1561744197\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLY\" target=\"_blank\">FSLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474712-fastlyplus-8_7-on-insider-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fastly +8.7% on insider purchase</a></h4><ul><li>Fastly (NYSE:<a href='https://seekingalpha.com/symbol/FSLY' title='Fastly, Inc.'>FSLY</a>) <font color=\"green\">gains 8.7%</font> after yesterday's after hours <a href=\"https://seekingalpha.com/filing/4547806\" target=\"_blank\">disclosure</a> that major shareholder Abdiel Capital Management acquired more than 153K shares.</li><li>The total included 58,125 shares at an average price of $17.13 each and 95,123 shares at $17.32.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474712\" data-linked=\"Fastly +8.7% on insider purchase\" data-tweet=\"$FSLY - Fastly +8.7% on insider purchase https://seekingalpha.com/news/3474712-fastlyplus-8_7-on-insider-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/3474712-fastlyplus-8_7-on-insider-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474701\" data-ts=\"1561741676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474701-mmtec-leads-financial-gainers-aamc-and-hhc-only-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mmtec leads financial gainers, AAMC and HHC the only losers</a></h4><ul><li><b>Gainers:</b> Mmtec (NASDAQ:<a href='https://seekingalpha.com/symbol/MTC' title='Mmtec, Inc.'>MTC</a>) <font color=\"green\">+20%</font>. Ocwen Financial (NYSE:<a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a>) <font color=\"green\">+12%</font>. The RMR Group (NASDAQ:<a href='https://seekingalpha.com/symbol/RMR' title='The RMR Group Inc.'>RMR</a>) <font color=\"green\">+8%</font>. CURO Group Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CURO' title='CURO Group Holdings Corp.'>CURO</a>) <font color=\"green\">+7%</font>. Puyi (NASDAQ:<a href='https://seekingalpha.com/symbol/PUYI' title='Puyi Inc.'>PUYI</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers:</b> Altisource Asset Management (NYSEMKT:<a href='https://seekingalpha.com/symbol/AAMC' title='Altisource Asset Management Corporation'>AAMC</a>) <font color=\"red\">-7%</font>. The Howard Hughes (NYSE:<a href='https://seekingalpha.com/symbol/HHC' title='The Howard Hughes Corporation'>HHC</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474701\" data-linked=\"Mmtec leads financial gainers, AAMC and HHC the only losers\" data-tweet=\"$MTC $OCN $RMR - Mmtec leads financial gainers, AAMC and HHC the only losers https://seekingalpha.com/news/3474701-mmtec-leads-financial-gainers-aamc-and-hhc-only-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474701-mmtec-leads-financial-gainers-aamc-and-hhc-only-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474699\" data-ts=\"1561741434\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474699-highpower-international-leads-industrial-gainers-cemtrex-only-loser\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Highpower International leads industrial gainers; Cemtrex only loser</a></h4><ul><li><b>Gainers: </b>Highpower International (NASDAQ:<a href='https://seekingalpha.com/symbol/HPJ' title='Highpower International, Inc.'>HPJ</a>) <font color=\"green\">+40%</font>. Broadwind Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/BWEN' title='Broadwind Energy, Inc.'>BWEN</a>) <font color=\"green\">+25%</font>. GMS (NYSE:<a href='https://seekingalpha.com/symbol/GMS' title='GMS Inc.'>GMS</a>) <font color=\"green\">+10%</font>. ClearSign Combustion (NASDAQ:<a href='https://seekingalpha.com/symbol/CLIR' title='ClearSign Combustion Corporation'>CLIR</a>) <font color=\"green\">+10%</font>.  Orion Group Holdings (NYSE:<a href='https://seekingalpha.com/symbol/ORN' title='Orion Group Holdings, Inc.'>ORN</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>Cemtrex (NASDAQ:<a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a>) <font color=\"red\">-19%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474699\" data-linked=\"Highpower International leads industrial gainers; Cemtrex only loser\" data-tweet=\"$HPJ $BWEN $GMS - Highpower International leads industrial gainers; Cemtrex only loser https://seekingalpha.com/news/3474699-highpower-international-leads-industrial-gainers-cemtrex-only-loser?source=tweet\" data-url=\"https://seekingalpha.com/news/3474699-highpower-international-leads-industrial-gainers-cemtrex-only-loser\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474693\" data-ts=\"1561740176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474693-srpt-rad-hcm-and-gtt-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SRPT, RAD, HCM, and GTT among midday movers</a></h4><ul><li><strong>Gainers</strong>: Foresight Autonomous (NASDAQ:<a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a>) <font color=\"green\">+65%</font>. Highpower International (NASDAQ:<a href='https://seekingalpha.com/symbol/HPJ' title='Highpower International, Inc.'>HPJ</a>) <font color=\"green\">+39%</font>. Avid Bioservices (NASDAQ:<a href='https://seekingalpha.com/symbol/CDMO' title='Avid Bioservices, Inc.'>CDMO</a>) <font color=\"green\">+32%</font>. Phunware (NASDAQ:<a href='https://seekingalpha.com/symbol/PHUN' title='Phunware, Inc.'>PHUN</a>) <font color=\"green\">+30%</font>. Xenetic Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a>) <font color=\"green\">+27%</font>. Motorcar Parts of America (NASDAQ:<a href='https://seekingalpha.com/symbol/MPAA' title='Motorcar Parts of America, Inc.'>MPAA</a>) <font color=\"green\">+25%</font>. Unum Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/UMRX' title='Unum Therapeutics Inc.'>UMRX</a>) <font color=\"green\">+17%</font>. Sarepta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a>) <font color=\"green\">+16%</font>.  CalAmp (NASDAQ:<a href='https://seekingalpha.com/symbol/CAMP' title='CalAmp Corp.'>CAMP</a>) <font color=\"green\">+15%</font>. ATA (NASDAQ:<a href='https://seekingalpha.com/symbol/ATAI' title='ATA Inc.'>ATAI</a>) <font color=\"green\">+14%</font>.</li> <li><strong>Losers</strong>: Hutchison China MediTech (NASDAQ:<a href='https://seekingalpha.com/symbol/HCM' title='Hutchison China MediTech Limited'>HCM</a>) <font color=\"red\">-25%</font>. Cemtrex (NASDAQ:<a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a>) <font color=\"red\">-18%</font>. Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) <font color=\"red\">-18%</font>. China SXT Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SXTC' title='China SXT Pharmaceuticals, Inc.'>SXTC</a>) <font color=\"red\">-16%</font>. Oasmia Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical AB &#40;publ&#41;'>OASM</a>) <font color=\"red\">-15%</font>. SSLJ.com (YGTY) <font color=\"red\">-10%</font>. GTT Communications (NYSE:<a href='https://seekingalpha.com/symbol/GTT' title='GTT Communications, Inc.'>GTT</a>) <font color=\"red\">-8%</font>. Prevail Therapeutics Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/PRVL' title='Prevail Therapeutics Inc.'>PRVL</a>) <font color=\"red\">-8%</font>. Rite Aid Corporation (NYSE:<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474693\" data-linked=\"SRPT, RAD, HCM, and GTT among midday movers\" data-tweet=\"$FRSX $HPJ $CDMO - SRPT, RAD, HCM, and GTT among midday movers https://seekingalpha.com/news/3474693-srpt-rad-hcm-and-gtt-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474693-srpt-rad-hcm-and-gtt-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474688\" data-ts=\"1561739167\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLGL\" target=\"_blank\">SLGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474688-sol-gel-inks-new-deal-perrigo-for-antibiotic-foams-shares-ahead-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sol-Gel inks new deal with Perrigo for antibiotic foams; shares ahead 2%</a></h4><ul><li>Sol-Gel Technologies (<a href='https://seekingalpha.com/symbol/SLGL' title='Sol-Gel Technologies Ltd.'>SLGL</a> <font color=\"green\">+1.6%</font>) has consummated its seventh collaboration <a href=\"https://seekingalpha.com/pr/17525589-sol-gel-technologies-announces-seventh-agreement-generic-product-candidates-perrigo\" target=\"_blank\">agreement </a>with Perrigo (<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company plc'>PRGO</a> <font color=\"green\">+1.7%</font>), this one aimed at the development, manufacture and commercialization of two new generic antibiotic foams.</li><li>Consistent with earlier deals, SLGL will pursue regulatory approval in the U.S. If successful, PRGO will commercialize. The companies will share development costs and gross profits.</li><li>Specific financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474688\" data-linked=\"Sol-Gel inks new deal with Perrigo for antibiotic foams; shares ahead 2%\" data-tweet=\"$SLGL $PRGO - Sol-Gel inks new deal with Perrigo for antibiotic foams; shares ahead 2% https://seekingalpha.com/news/3474688-sol-gel-inks-new-deal-perrigo-for-antibiotic-foams-shares-ahead-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3474688-sol-gel-inks-new-deal-perrigo-for-antibiotic-foams-shares-ahead-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474684\" data-ts=\"1561738445\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSLT\" target=\"_blank\">CSLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474684-castlight-up-7-on-new-data-security-certifications\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Castlight up 7% on new data security certifications</a></h4><ul><li>Castlight Health (<a href='https://seekingalpha.com/symbol/CSLT' title='Castlight Health, Inc.'>CSLT</a> <font color=\"green\">+6.5%</font>) is up, albeit on below-average volume, in response to its <a href=\"https://seekingalpha.com/pr/17559261-castlight-health-achieves-two-hitrust-certifications-underscoring-commitment-data-security\" target=\"_blank\">announcement </a>that it has earned two HITRUST certifications for information security, signifying that it has met stringent regulatory and industry-defined requirements and is effectively managing risk.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474684\" data-linked=\"Castlight up 7% on new data security certifications\" data-tweet=\"$CSLT - Castlight up 7% on new data security certifications https://seekingalpha.com/news/3474684-castlight-up-7-on-new-data-security-certifications?source=tweet\" data-url=\"https://seekingalpha.com/news/3474684-castlight-up-7-on-new-data-security-certifications\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474680\" data-ts=\"1561737845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474680-lifevantage-and-resolute-forest-products-among-consumer-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LifeVantage and Resolute Forest Products among consumer gainers</a></h4><ul><li><b>Gainers: </b>Motorcar Parts of America (NASDAQ:<a href='https://seekingalpha.com/symbol/MPAA' title='Motorcar Parts of America, Inc.'>MPAA</a>) <font color=\"green\">+22%</font>. Resolute Forest Products (NYSE:<a href='https://seekingalpha.com/symbol/RFP' title='Resolute Forest Products Inc.'>RFP</a>) <font color=\"green\">+8%</font>. LifeVantage (NASDAQ:<a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a>) <font color=\"green\">+8%</font>. Libbey (NYSEMKT:<a href='https://seekingalpha.com/symbol/LBY' title='Libbey Inc.'>LBY</a>) <font color=\"green\">+7%</font>. Bassett Furniture Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/BSET' title='Bassett Furniture Industries, Incorporated'>BSET</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>None</li></ul><div class=\"tiny-share-widget\" data-id=\"3474680\" data-linked=\"LifeVantage and Resolute Forest Products among consumer gainers\" data-tweet=\"$MPAA $RFP $LFVN - LifeVantage and Resolute Forest Products among consumer gainers https://seekingalpha.com/news/3474680-lifevantage-and-resolute-forest-products-among-consumer-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474680-lifevantage-and-resolute-forest-products-among-consumer-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474666\" data-ts=\"1561736280\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HYGS\" target=\"_blank\">HYGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474666-cummins-to-acquire-hydrogenics-for-15-share-in-cash\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cummins to acquire Hydrogenics for $15/share in cash</a></h4><ul> <li>Cummins (<a href='https://seekingalpha.com/symbol/CMI' title='Cummins Inc.'>CMI</a> <font color=\"green\">+0.4%</font>) has agreed to <a href=\"https://seekingalpha.com/pr/17559259-cummins-acquire-hydrogenics\" target=\"_blank\">acquire</a>, through a wholly-owned subsidiary, all the outstanding shares of fuel cell systems provider Hydrogenics Corporation (<a href='https://seekingalpha.com/symbol/HYGS' title='Hydrogenics Corporation'>HYGS</a> <font color=\"red\">-3.9%</font>) for $15/share in cash, representing an enterprise value of ~$290M.</li>    <li>The closing of the acquisition is subject to regulatory approvals in Canada.</li><li>The Hydrogen Company, which is also Hydrogenics\u2019 current largest equity shareholder, will maintain its ownership in Hydrogenics.</li><li>The transaction is expected to close in 3Q19.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474666\" data-linked=\"Cummins to acquire Hydrogenics for $15/share in cash\" data-tweet=\"$HYGS $CMI $CMI - Cummins to acquire Hydrogenics for $15/share in cash https://seekingalpha.com/news/3474666-cummins-to-acquire-hydrogenics-for-15-share-in-cash?source=tweet\" data-url=\"https://seekingalpha.com/news/3474666-cummins-to-acquire-hydrogenics-for-15-share-in-cash\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474667\" data-ts=\"1561735209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474667-realreal-pops-in-ipo-open\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The RealReal pops in IPO open</a></h4><ul> <li>The RealReal (NASDAQ:<a href='https://seekingalpha.com/symbol/REAL' title='The RealReal'>REAL</a>) opens for trading at $28 and has already swapped hands as high as $29.92.</li> <li>The IPO of the online luxury goods seller of consignment goods was priced last night at $20 per share.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3474667\" data-linked=\"The RealReal pops in IPO open\" data-tweet=\"$REAL - The RealReal pops in IPO open https://seekingalpha.com/news/3474667-realreal-pops-in-ipo-open?source=tweet\" data-url=\"https://seekingalpha.com/news/3474667-realreal-pops-in-ipo-open\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474663\" data-ts=\"1561734949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GO\" target=\"_blank\">GO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474663-insider-buying-grocery-outlet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Insider buying at Grocery Outlet</a></h4><ul> <li>Grocery Outlet Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/GO' title='Grocery Outlet Holding Corp.'>GO</a>) trades higher after the company reports a round of insider buying.</li> <li>President Robert Sheedy picked up 10K shares at $22 per share on July 24.</li> Shares of GO are <font color=\"green\">up 2.42%</font> on the day and trade 52% higher than the IPO pricing level. <ul><li><a href=\"https://seekingalpha.com/filing/4548236\" target=\"_blank\">SEC Form 4</a></li></ul> </ul><div class=\"tiny-share-widget\" data-id=\"3474663\" data-linked=\"Insider buying at Grocery Outlet\" data-tweet=\"$GO - Insider buying at Grocery Outlet https://seekingalpha.com/news/3474663-insider-buying-grocery-outlet?source=tweet\" data-url=\"https://seekingalpha.com/news/3474663-insider-buying-grocery-outlet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474656\" data-ts=\"1561734324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474656-avid-bioservices-and-immunogen-among-healthcare-gainers-hutchison-china-meditech-and-verastem\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avid Bioservices and ImmunoGen among healthcare gainers; Hutchison China MediTech and Verastem among losers</a></h4><ul><li><b>Gainers: </b>Avid Bioservices (NASDAQ:<a href='https://seekingalpha.com/symbol/CDMO' title='Avid Bioservices, Inc.'>CDMO</a>) <font color=\"green\">+31%</font>. Xenetic Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a>) <font color=\"green\">+19%</font>. Sarepta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a>) <font color=\"green\">+16%</font>. Axcella Health (NASDAQ:<a href='https://seekingalpha.com/symbol/AXLA' title='Axcella Health Inc.'>AXLA</a>) <font color=\"green\">+16%</font>. ImmunoGen (NASDAQ:<a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a>) <font color=\"green\">+13%</font>.</li><li><b>Losers: </b>Hutchison China MediTech (NASDAQ:<a href='https://seekingalpha.com/symbol/HCM' title='Hutchison China MediTech Limited'>HCM</a>) <font color=\"red\">-24%</font>. Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) <font color=\"red\">-19%</font>. Oasmia Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical AB &#40;publ&#41;'>OASM</a>) <font color=\"red\">-15%</font>. China SXT Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SXTC' title='China SXT Pharmaceuticals, Inc.'>SXTC</a>) <font color=\"red\">-12%</font>. Verastem (NASDAQ:<a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474656\" data-linked=\"Avid Bioservices and ImmunoGen among healthcare gainers; Hutchison China MediTech and Verastem among losers\" data-tweet=\"$CDMO $XBIO $SRPT - Avid Bioservices and ImmunoGen among healthcare gainers; Hutchison China MediTech and Verastem among losers https://seekingalpha.com/news/3474656-avid-bioservices-and-immunogen-among-healthcare-gainers-hutchison-china-meditech-and-verastem?source=tweet\" data-url=\"https://seekingalpha.com/news/3474656-avid-bioservices-and-immunogen-among-healthcare-gainers-hutchison-china-meditech-and-verastem\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474655\" data-ts=\"1561734270\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRSX\" target=\"_blank\">FRSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474655-foresight-up-80-on-china-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Foresight up 80% on China deal</a></h4><ul><li>Thinly traded nano cap Foresight Autonomous Holdings Ltd. (<a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a> <font color=\"green\">+79.9%</font>) is up on a whopping 200x surge in volume in reaction to its <a href=\"https://seekingalpha.com/pr/17559180-foresight-signs-agreement-chinese-tier-one-automotive-supplier\" target=\"_blank\">technology cooperation agreement</a> with a Chinese Tier One supplier to develop smart mobility solutions for the Chinese auto industry.</li><li>The company says the deal may enable it to incorporate its QuadSight vision system into existing products.</li><li>Financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474655\" data-linked=\"Foresight up 80% on China deal\" data-tweet=\"$FRSX - Foresight up 80% on China deal https://seekingalpha.com/news/3474655-foresight-up-80-on-china-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3474655-foresight-up-80-on-china-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474654\" data-ts=\"1561734098\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAG\" target=\"_blank\">CAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474654-baml-sticks-bullish-view-on-conagra-brands\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML sticks with bullish view on Conagra Brands</a></h4><ul> <li>Bank of America Merrill Lynch reiterates a Buy rating on Conagra Brands (<a href='https://seekingalpha.com/symbol/CAG' title='Conagra Brands, Inc.'>CAG</a> <font color='green'>+4.4%</font>) despite the Q4 earnings report stumble.</li> <li>\"We view the issues as temporary and addressable and see CAG well positioned to capitalize on innovation and synergies,\" updates the firm.</li> <li>BAML adjusts its price objective on CAG to $35 to rep 32% upside potential and top the <a href=\"https://seekingalpha.com/symbol/CAG/ratings/sell-side-ratings\" target=\"_blank\">sell-side consensus PT</a> of $32.63.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474654\" data-linked=\"BAML sticks with bullish view on Conagra Brands\" data-tweet=\"$CAG - BAML sticks with bullish view on Conagra Brands https://seekingalpha.com/news/3474654-baml-sticks-bullish-view-on-conagra-brands?source=tweet\" data-url=\"https://seekingalpha.com/news/3474654-baml-sticks-bullish-view-on-conagra-brands\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474648\" data-ts=\"1561733404\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMO\" target=\"_blank\">TMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474648-thermo-fisher-slips-1-on-customer-disruption\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thermo Fisher slips 1% on customer disruption</a></h4><ul><li>Thermo Fisher Scientific (<a href='https://seekingalpha.com/symbol/TMO' title='Thermo Fisher Scientific Inc.'>TMO</a> <font color=\"red\">-1.4%</font>) is down, albeit on light volume, in apparent response to a two-day customer disruption caused by a fire at a Pittsburgh, PA data center.</li><li>Customers were able to purchase products from its Life Technologies unit but not from Fisher Scientific.</li><li>Management has yet to comment on the matter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474648\" data-linked=\"Thermo Fisher slips 1% on customer disruption\" data-tweet=\"$TMO - Thermo Fisher slips 1% on customer disruption https://seekingalpha.com/news/3474648-thermo-fisher-slips-1-on-customer-disruption?source=tweet\" data-url=\"https://seekingalpha.com/news/3474648-thermo-fisher-slips-1-on-customer-disruption\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474645\" data-ts=\"1561732901\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRAM\" target=\"_blank\">MRAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474645-everspinminus-4-on-q2-outlook-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Everspin -4% on Q2 outlook cut</a></h4><ul><li>Everspin (NASDAQ:<a href='https://seekingalpha.com/symbol/MRAM' title='Everspin Technologies, Inc.'>MRAM</a>) <a href=\"https://seekingalpha.com/pr/17559122-everspin-revises-second-quarter-2019-guidance\" target=\"_blank\">lowers</a> the revenue guidance from $9.6-10M to $8.3-8.5M, citing lower than expected Toggle MRAM sales partially due to the Chinese manufacturing slowdown.</li><li>MRAM will report Q2 results on August 7.</li><li>Everspin shares are <font color=\"red\">down 4.4%</font> to $6.82.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474645\" data-linked=\"Everspin -4% on Q2 outlook cut\" data-tweet=\"$MRAM - Everspin -4% on Q2 outlook cut https://seekingalpha.com/news/3474645-everspinminus-4-on-q2-outlook-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3474645-everspinminus-4-on-q2-outlook-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474644\" data-ts=\"1561732814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474644-sarepta-jumps-19-fears-ebb-over-superiority-of-pfizer-dmd-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta jumps 19% as fears ebb over superiority of Pfizer DMD data</a></h4><ul><li>Sarepta Therapeutics (<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color=\"green\">+19.4%</font>) is up more than double normal as investors buy in after Pfizer's (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a>) data presentation this morning on DMD gene therapy candidate PF-06939926. Apparently, interim data from a small <a href=\"https://clinicaltrials.gov/ct2/show/NCT03362502?intr=pf-06939926&amp;rank=1\" target=\"_blank\">Phase 1 study</a> posed no real threat to Sarepta's AAVrh74.</li><li>PFE is up a fraction on below-average volume.</li><li><strong>Update</strong>: PFE <a href=\"https://seekingalpha.com/pr/17559287-pfizer-presents-initial-clinical-data-phase-1b-gene-therapy-study-duchenne-muscular-dystrophy\" target=\"_blank\">presented data</a> from six boys with DMD who received a one-time IV dose of PF-06939926. Immune response occurred in all six. One experienced a rapid antibody response with complement system activation associated with acute kidney injury. He was admitted to a pediatric ICU for hemodialysis and treatment with a complement inhibitor. He was discharged after 11 days and his kidney function returned to normal after 15 days. No other participants will be dosed until additional safety monitoring procedures have been approved at the trial sites.</li><li>On the efficacy front, muscle biopsies taken two months after dosing showed an average of 38% positive fibers (detectable mini-dystrophin via immunofluorescence) at the 1E14 vg/kg dose and 69% positive fibers at the 3E14 vg/kg dose. The data cutoff was too short for meaningful functional assessments. Only two participants had completed one year of follow-up. Both showed mean increases of 4.5 points (baselines of 24 and 25) in a motor ability scale called NSAA.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474644\" data-linked=\"Sarepta jumps 19% as fears ebb over superiority of Pfizer DMD data\" data-tweet=\"$SRPT $PFE - Sarepta jumps 19% as fears ebb over superiority of Pfizer DMD data https://seekingalpha.com/news/3474644-sarepta-jumps-19-fears-ebb-over-superiority-of-pfizer-dmd-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3474644-sarepta-jumps-19-fears-ebb-over-superiority-of-pfizer-dmd-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474641\" data-ts=\"1561732239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHC\" target=\"_blank\">VHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474641-virnetxplus-4_7-on-partial-appeals-court-win\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VirnetX +4.7% on partial appeals court win</a></h4><ul><li>VirnetX (NYSEMKT:<a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corp'>VHC</a>) <font color=\"green\">gains 4.7%</font> after the US Court of Appeals for the Federal Circuit rules in the company's favor against a Patent Trial and Appeal Board decision.</li><li>The appeals court <a href=\"https://seekingalpha.com/news/3468973-virnetx-plus-8-percent-appeals-court-hearing\" target=\"_blank\">vacates</a> the Board's decision on three VHC claims, saying it failed to address VHC's arguments and make necessary factual findings, and remands for further proceedings.</li><li>The court does affirm the rest of the Board's decisions regarding the secure communications patent infringement case against Apple.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474641\" data-linked=\"VirnetX +4.7% on partial appeals court win\" data-tweet=\"$VHC - VirnetX +4.7% on partial appeals court win https://seekingalpha.com/news/3474641-virnetxplus-4_7-on-partial-appeals-court-win?source=tweet\" data-url=\"https://seekingalpha.com/news/3474641-virnetxplus-4_7-on-partial-appeals-court-win\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474632\" data-ts=\"1561730891\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNH\" target=\"_blank\">UNH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474632-health-insurers-in-red-after-dem-debate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health insurers in red after Dem debate</a></h4><ul><li>Health insurers and managed care providers are under modest pressure following the conclusion of the two-day debate between Democratic candidates for President.</li><li>Of the 20 candidates, four support a government-run single payer system but there was disagreement on scrapping private health insurance coverage offered under the Affordable Care Act.</li><li>Selected tickers: UnitedHealth Group (<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Incorporated'>UNH</a> <font color=\"red\">-2.4%</font>), Anthem (<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a> <font color=\"red\">-1.4%</font>), Centene (<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a> <font color=\"red\">-1.4%</font>), Humana (<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color=\"red\">-1.3%</font>), WellCare Health Plans (<a href='https://seekingalpha.com/symbol/WCG' title='WellCare Health Plans, Inc.'>WCG</a> <font color=\"red\">-0.7%</font>), Molina Healthcare (<a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a> <font color=\"red\">-0.8%</font>), Cigna (<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color=\"red\">-0.6%</font>), eHealth (<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a> <font color=\"red\">-0.2%</font>), Health Insurance Innovations (<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations, Inc.'>HIIQ</a> <font color=\"green\">+1.1%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3474632\" data-linked=\"Health insurers in red after Dem debate\" data-tweet=\"$UNH $ANTM $CNC - Health insurers in red after Dem debate https://seekingalpha.com/news/3474632-health-insurers-in-red-after-dem-debate?source=tweet\" data-url=\"https://seekingalpha.com/news/3474632-health-insurers-in-red-after-dem-debate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>77&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474631\" data-ts=\"1561730761\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPAA\" target=\"_blank\">MPAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474631-motorcar-parts-of-america-jumpsplus-24-post-q4-results-provides-fy20-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Motorcar Parts of America jumps +24% post Q4 results; provides FY20 guidance</a></h4><ul><li>Motorcar Parts of America (<a href='https://seekingalpha.com/symbol/MPAA' title='Motorcar Parts of America, Inc.'>MPAA</a> <font color=\"green\">+24.3%</font>) reported Q4 sales growth of 7.8% Y/Y to $129.08M, due to sales increases for both hard parts and diagnostic products; and Adj. net sales were $132.7M (+7.5% Y/Y).</li><li>Q4 Gross margin <font color=\"red\">declined by 420 bps </font>to 20.1%; and operating margin <font color=\"red\">fell by 755 bps </font>to 4.3%.</li><li>Adj. Gross margin was flat at 29.4%.</li><li>Q4 Expenses: G&amp;A $12.55M (+38.6% Y/Y); Sales &amp; marketing $5.46M (+32.3% Y/Y); and R&amp;D $2.44M (+37.7% Y/Y).</li><li>Adj. EBITDA $24.83M (+11.9% Y/Y); and margin <font color=\"green\">improved by 71 bps </font>to 19.2%.</li><li>Company has Cash and cash equivalents of $9.91M as pf March 31, 2019.</li><li>Company says FY20 expected to benefit from multi-Product line expansion and investment initiatives from past few years.</li><li><strong>FY20 Guidance:</strong> Adj. Net sales $552M to $562M (organic growth Y/Y 16% to 18%); adj. gross margin ~27%. Profitability and cash flow are expected to improve on a year-over-year basis.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3474557-motorcar-parts-america-eps-beats-0_10-misses-revenue\" target=\"_blank\">Motorcar Parts of America EPS beats by $0.10, misses on revenue</a> (June 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3474631\" data-linked=\"Motorcar Parts of America jumps +24% post Q4 results; provides FY20 guidance\" data-tweet=\"$MPAA - Motorcar Parts of America jumps +24% post Q4 results; provides FY20 guidance https://seekingalpha.com/news/3474631-motorcar-parts-of-america-jumpsplus-24-post-q4-results-provides-fy20-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3474631-motorcar-parts-of-america-jumpsplus-24-post-q4-results-provides-fy20-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474627\" data-ts=\"1561730373\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DB\" target=\"_blank\">DB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474627-deutsche-bank-gears-up-for-heavy-job-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank gears up for heavy job cuts</a></h4><ul><li>Deutsche Bank (<a href='https://seekingalpha.com/symbol/DB' title='Deutsche Bank Aktiengesellschaft'>DB</a> <font color='green'>+2.7%</font>) could target <a href=\"https://www.wsj.com/articles/deutsche-bank-considers-up-to-20-000-job-cuts-11561728703?mod=hp_lead_pos3\" target=\"_blank\">15,000 to 20,000 job cuts</a>, or more than one in six full-time positions globally, the <em>Wall Street Journal </em>reports, citing a person familiar with high-level talks about turning around the struggling bank.</li><li>The cuts being considered reflect an acceleration of the bank's downsizing. If Deutsche Bank follows through, the cut would represent 16%-22% of its workforce of 91,463 employees the bank said it had at the end of March.</li><li>Deutsche Bank's U.S. operations and the investment bank in general is expected to see heavy cuts, the <em>WSJ s</em>aid.</li><li>Germany's largest lender may cut<a href=\"https://www.bloomberg.com/news/articles/2019-06-28/deutsche-bank-plans-to-cut-as-many-as-half-of-global-equity-jobs?srnd=premium\" target=\"_blank\"> as much as half</a> of its global equities trading workforce as part of its broader push to boost profitability, Bloomberg reports, citing people with knowledge of the matter.</li><li>The bank is expected to start notifying staff of the job cuts, including in the U.S. and Asia, as soon as July, according to the Bloomberg article, which notes that rates trading will also be affected.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474627\" data-linked=\"Deutsche Bank gears up for heavy job cuts\" data-tweet=\"$DB - Deutsche Bank gears up for heavy job cuts https://seekingalpha.com/news/3474627-deutsche-bank-gears-up-for-heavy-job-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3474627-deutsche-bank-gears-up-for-heavy-job-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474625\" data-ts=\"1561730202\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HYGS\" target=\"_blank\">HYGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474625-hydrogenics-announces-arrangement-agreement-cummins-inc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hydrogenics announces arrangement agreement with Cummins Inc</a></h4><ul><li>Hydrogenics (<a href='https://seekingalpha.com/symbol/HYGS' title='Hydrogenics Corporation'>HYGS</a>) has <a href=\"https://seekingalpha.com/pr/17559245-hydrogenics-corporation-announces-arrangement-agreement-cummins-inc\" target=\"_blank\">entered into an arrangement agreement</a> with Cummins and Atlantis AcquisitionCo Canada.</li><li>Pursuant to the arrangement, subsidiary of Cummins Inc. will acquire all of the outstanding common shares of the company, other than Shares owned by The Hydrogen Company (subsidiary of L\u2019Air Liquide S.A.) for $15.00/share in cash.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474625\" data-linked=\"Hydrogenics announces arrangement agreement with Cummins Inc\" data-tweet=\"$HYGS - Hydrogenics announces arrangement agreement with Cummins Inc https://seekingalpha.com/news/3474625-hydrogenics-announces-arrangement-agreement-cummins-inc?source=tweet\" data-url=\"https://seekingalpha.com/news/3474625-hydrogenics-announces-arrangement-agreement-cummins-inc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474624\" data-ts=\"1561730120\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474624-calampplus-13-analysts-react-to-q1-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CalAmp +13% as analysts react to Q1 beat</a></h4><ul>   <li>CalAmp (NASDAQ:<a href='https://seekingalpha.com/symbol/CAMP' title='CalAmp Corp.'>CAMP</a>) is among Nasdaq's top gainers, <font color=\"green\">up 13%</font> out of today's open after <a href=\"https://seekingalpha.com/news/3474440-calamp-plus-7_8-percent-q1-profits-top-highest-estimates\" target=\"_blank\">yesterday's Q1 earnings</a> came up with profits that topped high Street expectations, and analysts produced positive talk this morning.</li>    <li>Northland Securities took the opportunity to upgrade the stock to Outperform, raising its price target to $20 from $17; that implies a healthy 70% upside from today's already-higher price of $11.75.</li>    <li>Roth Capital Partners has been bullish and notes the results should be a \"welcome relief\" as it looks like the Telematics Systems business is stabilizing. It has an $18 price target.</li>    <li>Jefferies, which rates the stock Hold, acknowledges solid results but points to slowing organic growth in a time of macro uncertainty. It has a price target of $14.</li>   <li><a href=\"https://seekingalpha.com/article/4272586-calamp-corp-camp-ceo-michael-burdiek-fiscal-q1-2020-results-earnings-call-transcript\" target=\"_blank\">Earnings call transcript</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3474624\" data-linked=\"CalAmp +13% as analysts react to Q1 beat\" data-tweet=\"$CAMP - CalAmp +13% as analysts react to Q1 beat https://seekingalpha.com/news/3474624-calampplus-13-analysts-react-to-q1-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3474624-calampplus-13-analysts-react-to-q1-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474615\" data-ts=\"1561728990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZO\" target=\"_blank\">AZO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474615-autozone-tracks-higher-after-oppenheimer-nod\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AutoZone tracks higher after Oppenheimer nod</a></h4><ul> <li>Oppenheimer lifts AutoZone (<a href='https://seekingalpha.com/symbol/AZO' title='AutoZone, Inc.'>AZO</a> <font color='green'>+0.3%</font>) to an Outperform rating from Perform after meeting with the retailer's management last week.</li> <li>\"We are now incrementally optimistic in the underlying potential for shares. Nearer-term, unfavorable weather and elevated investment spending could represent challenges for AZO. That said, over the intermediate to longer-term, sustained outsized commercial sales expansion should serve as an increasingly meaningful overall fundamental driver for the chain and a catalyst to close further the multiple gap between shares of AZO and those of its historically better positioned competitors,\" updates analyst Brian Nagel.</li> <li>Oppenheimer's price target of $1,225 on AutoZone is above the <a href=\"https://seekingalpha.com/symbol/AZO/ratings/sell-side-ratings\" target=\"_blank\">sell-side average PT</a> of $1,103.82.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474615\" data-linked=\"AutoZone tracks higher after Oppenheimer nod\" data-tweet=\"$AZO - AutoZone tracks higher after Oppenheimer nod https://seekingalpha.com/news/3474615-autozone-tracks-higher-after-oppenheimer-nod?source=tweet\" data-url=\"https://seekingalpha.com/news/3474615-autozone-tracks-higher-after-oppenheimer-nod\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474603\" data-ts=\"1561728334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYV\" target=\"_blank\">LYV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474603-live-nationminus-2_1-citi-cuts-to-sell-on-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Live Nation -2.1% as Citi cuts to Sell on valuation</a></h4><ul>   <li>Live Nation (NYSE:<a href='https://seekingalpha.com/symbol/LYV' title='Live Nation Entertainment, Inc.'>LYV</a>) is <font color=\"red\">2.1% lower</font> premarket after a cut to Sell at Citi, from Neutral.</li>    <li>The company's had solid growth, but valuation looked \"stretched\" and it trades at a big premium, analyst Jason Bazinet says: \"Investors have either become too willing to pay a premium for growth, or investors are making some valuation mistakes to arrive at the prevailing equity value.\"</li>    <li>Many valuation analyses don't take into account issues like balance sheet cash, operating leases and growth capital expenditures, he notes.</li>    <li>Sell-side analysts overall <a href=\"https://seekingalpha.com/symbol/LYV/ratings/sell-side-ratings\" target=\"_blank\">rate the stock an Outperform</a>, while <a href=\"https://seekingalpha.com/symbol/LYV/ratings/author-ratings\" target=\"_blank\">Seeking Alpha authors are Neutral</a> and it has a <a href=\"https://seekingalpha.com/symbol/LYV/ratings/quant-ratings\" target=\"_blank\">Quant Rating of Neutral</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3474603\" data-linked=\"Live Nation -2.1% as Citi cuts to Sell on valuation\" data-tweet=\"$LYV - Live Nation -2.1% as Citi cuts to Sell on valuation https://seekingalpha.com/news/3474603-live-nationminus-2_1-citi-cuts-to-sell-on-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3474603-live-nationminus-2_1-citi-cuts-to-sell-on-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474598\" data-ts=\"1561727906\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRNE\" target=\"_blank\">SRNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474598-sorrento-therapeutics-down-26-premarket-on-pricing-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sorrento Therapeutics down 26% premarket on pricing equity offering</a></h4><ul> <li>Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) <a href=\"https://seekingalpha.com/pr/17559150-sorrento-therapeutics-announces-pricing-underwritten-public-offering-common-stock-warrants\" target=\"_blank\">prices</a> its public offering of 8,333,334 common shares, Series A, Series B and Series C warrants to purchase 8,333,334 common shares, at a price of $3.00/share and accompanying warrants.</li><li>The Series A, B and C warrants have exercise price of $3.75 /share, $3.00/share and $3.75/share, respectively.</li><li>Expected gross proceeds are ~$25M.</li><li>Closing date is July 2.</li><li>Shares are down <font color=\"red\">26%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3474525-sorrento-therapeutics-launches-equity-offering-shares-17-percent-premarket\" target=\"_blank\">Sorrento Therapeutics launches equity offering; shares down 17% premarket</a> (June 28)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3474598\" data-linked=\"Sorrento Therapeutics down 26% premarket on pricing equity offering\" data-tweet=\"$SRNE - Sorrento Therapeutics down 26% premarket on pricing equity offering https://seekingalpha.com/news/3474598-sorrento-therapeutics-down-26-premarket-on-pricing-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3474598-sorrento-therapeutics-down-26-premarket-on-pricing-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474599\" data-ts=\"1561727906\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAL\" target=\"_blank\">AAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474599-faa-eyes-american-airlines-labor-dispute\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FAA eyes American Airlines labor dispute</a></h4><ul> <li>The FAA has intejected itself into a dispute between American Airlines Group (NASDAQ:<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group Inc.'>AAL</a>) and its mechanics union by raising concerns over the airline's safety management system.</li> <li>The agency doesn't want the union to slow down aircraft repairs as a negotiating tool.</li> <li>Shares of AAL are <font color=\"green\">up 1.09%</font> premarket to $32.50, but are flat for 2019.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474599\" data-linked=\"FAA eyes American Airlines labor dispute\" data-tweet=\"$AAL - FAA eyes American Airlines labor dispute https://seekingalpha.com/news/3474599-faa-eyes-american-airlines-labor-dispute?source=tweet\" data-url=\"https://seekingalpha.com/news/3474599-faa-eyes-american-airlines-labor-dispute\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474596\" data-ts=\"1561727842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPJ\" target=\"_blank\">HPJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474596-highpower-international-to-go-private-4_80-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Highpower International to go private at $4.80/share</a></h4><ul><li>Battery maker Highpower International (NASDAQ:<a href='https://seekingalpha.com/symbol/HPJ' title='Highpower International, Inc.'>HPJ</a>) <font color=\"green\">+38%</font> pre-market after <a href=\"https://seekingalpha.com/pr/17559127-highpower-international-enters-definitive-agreement-acquired-consortium-going-private\" target=\"_blank\">agreeing to be acquired</a> by a consortium consisting of Chairman and CEO George Pan, two company shareholders and Hong Kong-based Essence International Capital.</li><li>The consortium's $4.80/share cash offer represents a ~67% premium over HPJ's $2.88 closing price on June 1, 2018, the last  trading day prior to the company's announcement of its receipt of a  \"going-private\" proposal.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474596\" data-linked=\"Highpower International to go private at $4.80/share\" data-tweet=\"$HPJ - Highpower International to go private at $4.80/share https://seekingalpha.com/news/3474596-highpower-international-to-go-private-4_80-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3474596-highpower-international-to-go-private-4_80-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474593\" data-ts=\"1561727610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474593-riot-hpj-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RIOT, HPJ among premarket gainers</a></h4><ul><li>Highpower International (NASDAQ:<a href='https://seekingalpha.com/symbol/HPJ' title='Highpower International, Inc.'>HPJ</a>) <font color=\"green\">+41%</font> on being <a href=\"https://seekingalpha.com/pr/17559127-highpower-international-enters-definitive-agreement-acquired-consortium-going-private\" target=\"_blank\">acquired</a> by consortium in going private transaction.</li><li>Foresight Autonomous Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a>) <font color=\"green\">+26%</font> on signing <a href=\"https://seekingalpha.com/pr/17559180-foresight-signs-agreement-chinese-tier-one-automotive-supplier\" target=\"_blank\">agreement</a> with a Chinese Tier One supplier.</li><li>ATA (NASDAQ:<a href='https://seekingalpha.com/symbol/ATAI' title='ATA Inc.'>ATAI</a>) <font color=\"green\">+19%</font> on entering into <a href=\"https://seekingalpha.com/pr/17559094-ata-announces-entry-definitive-agreement-acquire-acg-leading-china-based-service-provider\" target=\"_blank\">agreement</a> with Beijing Huanqiuyimeng Education Consultation and certain of its major shareholders and core management members for the acquisition of ACG.</li><li>Avid Bioservices CDMO <font color=\"green\">+20%</font> on <a href=\"https://seekingalpha.com/news/3474474-avid-bioservices-eps-beats-0_01-beats-revenue\" target=\"_blank\">Q4 results</a>.</li><li>CalAmp CAMP <font color=\"green\">+19%</font> on <a href=\"https://seekingalpha.com/news/3474426-calamp-eps-beats-0_03-beats-revenue\" target=\"_blank\">Q1 results</a>.</li><li>Constellation Brands STZ <font color=\"green\">+8%</font> on <a href=\"https://seekingalpha.com/news/3474541-constellation-brands-eps-beats-0_15-beats-revenue\" target=\"_blank\">Q1 results</a>.</li><li>Phunware (NASDAQ:<a href='https://seekingalpha.com/symbol/PHUN' title='Phunware, Inc.'>PHUN</a>) <font color=\"green\">+8%</font> on <a href=\"https://seekingalpha.com/pr/17559140-phunware-join-ftse-russell-2000-russell-3000-indices\" target=\"_blank\">joining</a> FTSE Russell 2000 and Russell 3000 index.</li><li>Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"green\">+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474593\" data-linked=\"RIOT, HPJ among premarket gainers\" data-tweet=\"$HPJ $FRSX $AACG - RIOT, HPJ among premarket gainers https://seekingalpha.com/news/3474593-riot-hpj-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474593-riot-hpj-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474591\" data-ts=\"1561727387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474591-hcm-and-srne-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HCM and SRNE among premarket losers</a></h4><ul><li>Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) <font color=\"red\">-27%</font> on <a href=\"https://seekingalpha.com/news/3474525-sorrento-therapeutics-launches-equity-offering-shares-17-percent-premarket\" target=\"_blank\">launching</a> equity offering.</li><li>Hutchison China MediTech (NASDAQ:<a href='https://seekingalpha.com/symbol/HCM' title='Hutchison China MediTech Limited'>HCM</a>) <font color=\"red\">-20%</font> on <a href=\"https://seekingalpha.com/news/3474535-chi-med-prices-upsized-ads-offering-shares-11-percent-premarket\" target=\"_blank\">pricing</a> upsized ADS offering.</li><li>Cemtrex (NASDAQ:<a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a>) <font color=\"red\">-19%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474591\" data-linked=\"HCM and SRNE among premarket losers\" data-tweet=\"$SRNE $HCM $CETX - HCM and SRNE among premarket losers https://seekingalpha.com/news/3474591-hcm-and-srne-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474591-hcm-and-srne-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474589\" data-ts=\"1561727088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESTA\" target=\"_blank\">ESTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474589-janney-jumps-on-board-avid-after-q4-beat-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Janney jumps on board with Avid after Q4 beat in premarket analyst action</a></h4><ul><li>Establishment Labs Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/ESTA' title='Establishment Labs Holdings Inc.'>ESTA</a>) initiated with Outperform rating and $29 (38% upside) price target at Wells Fargo.</li><li>Novocure (NASDAQ:<a href='https://seekingalpha.com/symbol/NVCR' title='NovoCure Limited'>NVCR</a>) initiated with Outperform rating and $75 (23% upside) price target at Oppenheimer. Shares up <font color=\"green\">1% </font>premarket.</li><li>Merus N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/MRUS' title='Merus N.V.'>MRUS</a>) initiated with Buy rating and $20 (42% upside) price target at ROTH Capital.</li><li>Avid Bioservices (NASDAQ:<a href='https://seekingalpha.com/symbol/CDMO' title='Avid Bioservices, Inc.'>CDMO</a>) upgraded to Buy with a $10 (150% upside) price target at Janney after its fiscal Q4 beat. Shares up <font color=\"green\">20% </font>premarket.</li><li>Arrowhead Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals, Inc.'>ARWR</a>) downgraded to Neutral with a $24 (17% downside risk) price target. Shares down <font color=\"red\">2% </font>premarket.</li><li>Biogen (NASDAQ:<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a>) downgraded to Neutral at Piper Jaffray. Shares down <font color=\"red\">1%</font> premarket.</li><li>Inogen (NASDAQ:<a href='https://seekingalpha.com/symbol/INGN' title='Inogen, Inc.'>INGN</a>) downgraded to Buy from Strong Buy at Needham. Price target trimmed to $91 (40% upside).</li></ul><div class=\"tiny-share-widget\" data-id=\"3474589\" data-linked=\"Janney jumps on board with Avid after Q4 beat in premarket analyst action\" data-tweet=\"$ESTA $NVCR $CDMO - Janney jumps on board with Avid after Q4 beat in premarket analyst action https://seekingalpha.com/news/3474589-janney-jumps-on-board-avid-after-q4-beat-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3474589-janney-jumps-on-board-avid-after-q4-beat-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474588\" data-ts=\"1561726937\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LODE\" target=\"_blank\">LODE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474588-comstock-mining-inks-deal-for-mercury-remediation-systems\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comstock Mining inks deal for mercury remediation systems</a></h4><ul><li>Comstock Mining (NYSEMKT:<a href='https://seekingalpha.com/symbol/LODE' title='Comstock Mining Inc.'>LODE</a>) <font color=\"green\">+5.2%</font> pre-market on reaching agreement for the <a href=\"https://seekingalpha.com/pr/17558975-comstock-mining-signs-definitive-agreement-mercury-remediation-systems\" target=\"_blank\">manufacture and global deployment</a> of mercury remediation systems to reclaim, treat and remediate mercury from tailings and industrial waste from mining and other industrial applications.</li><li>Oro Industries will own all intellectual property and Mercury Clean Up will hold the exclusive worldwide rights to the proprietary mercury treatment system; MCU, in partnership with LODE, will deploy the solution globally.</li><li>LODE says it will invest $2M in MCU, with right of first refusal  on both business and capital investments, and will as much as 25% of  MCU as well as 50% of a new 50-50 Comstock Mercury Remediation venture.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474588\" data-linked=\"Comstock Mining inks deal for mercury remediation systems\" data-tweet=\"$LODE - Comstock Mining inks deal for mercury remediation systems https://seekingalpha.com/news/3474588-comstock-mining-inks-deal-for-mercury-remediation-systems?source=tweet\" data-url=\"https://seekingalpha.com/news/3474588-comstock-mining-inks-deal-for-mercury-remediation-systems\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474583\" data-ts=\"1561726208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFE\" target=\"_blank\">PFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474583-eyes-on-pfizer-ahead-of-update-on-dmd-gene-therapy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eyes on Pfizer ahead of update on DMD gene therapy</a></h4><ul><li>DMD gene therapy players may see some volatility this morning when Pfizer (NYSE:<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a>) presents updated data this morning on DMD gene therapy candidate PF-06939926 at the <a href=\"https://www.parentprojectmd.org/get-involved/attend-events/annual-conference/\" target=\"_blank\">Parent Project Muscular Dystrophy Annual Conference</a> in Orlando, FL.</li><li>Gene therapy competitors Sarepta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a>) (up a fraction) and Solid Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences Inc.'>SLDB</a>) (<font color=\"green\">+11%</font>) are already on the move.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474583\" data-linked=\"Eyes on Pfizer ahead of update on DMD gene therapy\" data-tweet=\"$PFE $SRPT $SLDB - Eyes on Pfizer ahead of update on DMD gene therapy https://seekingalpha.com/news/3474583-eyes-on-pfizer-ahead-of-update-on-dmd-gene-therapy?source=tweet\" data-url=\"https://seekingalpha.com/news/3474583-eyes-on-pfizer-ahead-of-update-on-dmd-gene-therapy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474579\" data-ts=\"1561725697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474579-nike-says-ready-for-macro-wildcards\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nike says it&#39;s ready for macro wildcards</a></h4><ul> <li>Nike (NYSE:<a href='https://seekingalpha.com/symbol/NKE' title='NIKE, Inc.'>NKE</a>) is down slightly in premarket trading after an EPS miss and only reiterating FY20 guidance during its post-earnings conference call (<a href=\"https://seekingalpha.com/article/4272580-nike-inc-nke-ceo-mark-parker-q4-2019-results-earnings-call-transcript\" target=\"_blank\">transcript</a>).</li> <li>During the call, Nike management warned that F/X pressure has increased from the prior quarter. However, CFO Andy Campion sounded pretty confident on the question of the positioning of Nike amid a potential continuation of the U.S.-China trade battle.</li><li>\"Our exposure in terms of product produced in China to North America is relatively modest. At the same time we see a great opportunity to continue and potentially expand the production of product in China, for China and for other markets,\" stated Campion.</li> <li>\"The short of it is we've got a relatively agile approach to sourcing multiple nodes from a production and distribution perspective. And so while the dynamics are certainly -- while it is certainly dynamic out there with respect to trade, we're relatively well positioned as we always have been for macro dynamics,\" he added.</li> <li>NKE <font color=\"red\">-0.49%</font> premarket to $83.25.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3474437-nike-eps-misses-0_04-beats-revenue\" target=\"_blank\">Nike EPS misses by $0.04, beats on revenue</a> (June 27)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3474446-nike-minus-2-percent-profit-miss\" target=\"_blank\">Nike -2% after profit miss</a> (June 27)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474579\" data-linked=\"Nike says it&#39;s ready for macro wildcards\" data-tweet=\"$NKE - Nike says it&#39;s ready for macro wildcards https://seekingalpha.com/news/3474579-nike-says-ready-for-macro-wildcards?source=tweet\" data-url=\"https://seekingalpha.com/news/3474579-nike-says-ready-for-macro-wildcards\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474577\" data-ts=\"1561725250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDMO\" target=\"_blank\">CDMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474577-avid-bio-up-14-premarket-on-fq4-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avid Bio up 14% premarket on FQ4 beat</a></h4><ul><li>Avid Bioservices (NASDAQ:<a href='https://seekingalpha.com/symbol/CDMO' title='Avid Bioservices, Inc.'>CDMO</a>) <a href=\"https://seekingalpha.com/pr/17558583-avid-bioservices-reports-financial-results-quarter-fiscal-year-ended-april-30-2019-recent\" target=\"_blank\">fiscal Q4</a> highlights:</li><li>Revenue up 146% to $17.1M. Backlog at quarter-end (April 30): ~$46M.</li><li>Net income: $336K (-89%).</li><li>Cash and equivalents at quarter-end: $32.4M (-23%).</li><li><strong>Fiscal 2020 guidance</strong>: Revenue: $64M - 67M.</li><li>Shares are up <font color=\"green\">14%</font> premarket on modestly higher volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3474474-avid-bioservices-eps-beats-0_01-beats-revenue\" target=\"_blank\">Avid Bioservices EPS beats by $0.01, beats on revenue</a> (June 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3474577\" data-linked=\"Avid Bio up 14% premarket on FQ4 beat\" data-tweet=\"$CDMO - Avid Bio up 14% premarket on FQ4 beat https://seekingalpha.com/news/3474577-avid-bio-up-14-premarket-on-fq4-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3474577-avid-bio-up-14-premarket-on-fq4-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474572\" data-ts=\"1561724947\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474572-firm-sees-upsides-in-wdcs-power-outage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Firm sees upsides in WDC&#39;s power outage</a></h4><ul><li>Morgan Stanley doesn't expect the <a href=\"https://seekingalpha.com/news/3474467-western-digital-outlines-power-outage-impact\" target=\"_blank\">power outage</a> announced by Western Digital (NASDAQ:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) yesterday to have a large impact on the business and says the \"press release seems aimed at customers -- perhaps in part with a hope of improving pricing -- as much as investors.\"</li><li>The firm says the news \"creates a downward bias to short- term numbers,\" which is offset by benefits to the mix in H2 and potentially to industry pricing next year.</li><li>Morgan Stanley maintains an Equal-Weight rating and $46 price target.</li><li>WDC shares are <font color=\"green\">up 2.7%</font> pre-market to $45.76.</li><li>Western Digital has a Neutral <a href=\"https://seekingalpha.com/symbol/WDC/ratings/quant-ratings\" target=\"_blank\">Quant rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474572\" data-linked=\"Firm sees upsides in WDC&#39;s power outage\" data-tweet=\"$WDC - Firm sees upsides in WDC&#39;s power outage https://seekingalpha.com/news/3474572-firm-sees-upsides-in-wdcs-power-outage?source=tweet\" data-url=\"https://seekingalpha.com/news/3474572-firm-sees-upsides-in-wdcs-power-outage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474570\" data-ts=\"1561724561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFE\" target=\"_blank\">PFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474570-fda-oks-pfizers-avastin-biosimilar-shares-up-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Pfizer&#39;s Avastin biosimilar; shares up 1% premarket</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17559031-pfizer-receives-u-s-fda-approval-oncology-biosimilar-zirabev-bevacizumab-bvzr\" target=\"_blank\">approves </a>Pfizer's (NYSE:<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a>) Zirabev (bevacizumab-bvzr), its biosimilar to Roche's (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding AG'>OTCQX:RHHBY</a>) cancer med Avastin.</li><li>Shares are up <font color=\"green\">1%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474570\" data-linked=\"FDA OKs Pfizer&#39;s Avastin biosimilar; shares up 1% premarket\" data-tweet=\"$PFE $RHHBY - FDA OKs Pfizer&#39;s Avastin biosimilar; shares up 1% premarket https://seekingalpha.com/news/3474570-fda-oks-pfizers-avastin-biosimilar-shares-up-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3474570-fda-oks-pfizers-avastin-biosimilar-shares-up-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474559\" data-ts=\"1561723535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUY\" target=\"_blank\">AUY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474559-outlook-bright-for-jacobina-mine-yamana-gold-says-in-lifting-production-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Outlook bright for Jacobina mine, Yamana Gold says in lifting production view</a></h4><ul><li>Yamana Gold (NYSE:<a href='https://seekingalpha.com/symbol/AUY' title='Yamana Gold Inc.'>AUY</a>) <font color=\"green\">+2.4%</font> pre-market after <a href=\"https://seekingalpha.com/pr/17558799-yamana-gold-increases-gold-production-guidance-updates-improved-strategic-life-mine-plan\" target=\"_blank\">raising gold production guidance</a> for its Jacobina mine in Brazil.</li><li>The mine produced more than 144K oz. of gold in 2018, and the company says it is a year ahead of schedule in its plans to increase  sustainable production to 150K oz./year and now forecasts life  of mine production of more than 170K oz./year after 2021.</li><li>AUY says it is considering a Phase 2 plant expansion to gradually increase Jacobina's gold production to  at least 200K oz./year and up to 225K oz./year by  2023 based on current mineral reserve grades.</li><li>Jacobina \"is on the cusp of becoming a world class mine, particularly once a  decision is made to proceed with the Phase 2 expansion,\" the company says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474559\" data-linked=\"Outlook bright for Jacobina mine, Yamana Gold says in lifting production view\" data-tweet=\"$AUY - Outlook bright for Jacobina mine, Yamana Gold says in lifting production view https://seekingalpha.com/news/3474559-outlook-bright-for-jacobina-mine-yamana-gold-says-in-lifting-production-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3474559-outlook-bright-for-jacobina-mine-yamana-gold-says-in-lifting-production-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474556\" data-ts=\"1561723305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474556-constellation-brandsplus-7-after-strong-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Constellation Brands +7% after strong quarter</a></h4><ul> <li>Constellation Brands (NYSE:<a href='https://seekingalpha.com/symbol/STZ' title='Constellation Brands, Inc.'>STZ</a>) rallies after topping FQ1 profit estimates by a wide margin and raising FY20 guidance.</li> <li>Beer sales were $1.48B on shipments growth of 5.4% during the quarter and wine/spirits sales were $620M on shipments growth of -8.1%.</li> <li>During FQ4, Constellation generates operating cash flow of $593M (+18% Y/Y) and free cash flow of $437M (+30%).</li> <li>CEO update:\" Our wine and spirits transformation strategy is working led by our collection of Power Brands, which delivered industry leading depletion growth of 4% during the quarter. In addition, our iconic beer portfolio continues to be a cornerstone of growth in the U.S. beer industry driven by double-digit depletion growth for Modelo Especial and Corona Premier.\"</li> <li>Looking ahead, the company expects FY20 EPS of $8.65 to $8.95 from $8.50 to $8.80 prior and $8.57 consensus.</li> <li>Shares of STZ are <font color=\"green\">up 7.28%</font> premarket to $202.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474556\" data-linked=\"Constellation Brands +7% after strong quarter\" data-tweet=\"$STZ - Constellation Brands +7% after strong quarter https://seekingalpha.com/news/3474556-constellation-brandsplus-7-after-strong-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3474556-constellation-brandsplus-7-after-strong-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474551\" data-ts=\"1561723023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGH\" target=\"_blank\">SGH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474551-needham-upgrades-smart-global-after-misses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham upgrades Smart Global after misses</a></h4><ul><li>Needham upgrades Smart Global (NASDAQ:<a href='https://seekingalpha.com/symbol/SGH' title='SMART Global Holdings, Inc.'>SGH</a>) from Hold to Buy and maintains a $32 PT after yesterday's <a href=\"https://seekingalpha.com/news/3474434-smart-global-minus-13_4-percent-weak-q4-outlook\" target=\"_blank\">Q3 misses</a> and weak Q4 outlook.</li><li>The firm says SGH's Brazil segment \"is bottoming out and should stabilize in FY20\" while gross margins are recovering with more room to grow.</li><li>Smart Global shares are <font color=\"red\">down 7.1%</font> pre-market to $19.99.</li><li>SGH has an Outperform average <a href=\"https://seekingalpha.com/symbol/SGH/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474551\" data-linked=\"Needham upgrades Smart Global after misses\" data-tweet=\"$SGH - Needham upgrades Smart Global after misses https://seekingalpha.com/news/3474551-needham-upgrades-smart-global-after-misses?source=tweet\" data-url=\"https://seekingalpha.com/news/3474551-needham-upgrades-smart-global-after-misses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474548\" data-ts=\"1561722556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474548-facebook-target-boosted-on-libra-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook target boosted on Libra potential</a></h4><ul><li>Loop Capital maintains a Buy rating on Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook, Inc.'>FB</a>) and raises its target from $200 to $225.</li><li>The firm cites FB's recently announced cryptocurrency plans, saying Libra will \"help balance the narrative on FB to innovation and another step towards monetization of its messaging platforms.\"</li><li>Analyst Alan Gould doesn't expect \"meaningful impact\" from Libra for a few years and says it's \"aggressive\" for FB to target a H1 2020 launch.</li><li>The analyst thinks FB should continue to top quarterly estimates since advertisers have \"few alternatives\" to Facebook's reach and targeting capabilities.</li><li>Facebook shares are <font color=\"green\">up 0.4%</font> pre-market to $190.26.</li><li>FB has an Outperform <a href=\"https://seekingalpha.com/symbol/FB/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474548\" data-linked=\"Facebook target boosted on Libra potential\" data-tweet=\"$FB - Facebook target boosted on Libra potential https://seekingalpha.com/news/3474548-facebook-target-boosted-on-libra-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3474548-facebook-target-boosted-on-libra-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474542\" data-ts=\"1561721865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JKS\" target=\"_blank\">JKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474542-jinkosolar-q1-module-shipments-jumped-50-y-y-topping-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JinkoSolar Q1 module shipments jumped 50% Y/Y, topping guidance</a></h4><ul><li>JinkoSolar (NYSE:<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>) <font color=\"green\">+2.2%</font> pre-market after posting better than expected <a href=\"https://seekingalpha.com/news/3474514-jinkosolar-holding-eps-beats-0_02-misses-revenue\" target=\"_blank\">Q1 earnings</a> and a 27% Y/Y growth in revenue to $867M, as module shipments surged 50% Y/Y to 3,037 MW; the company previously guided for Q1 shipments of 2.8-3.0 GW.</li><li>JKS says Q1 gross margin came in at 16.6%, compared with 14.7% in Q4 2018 and 14.4% in the year-ago quarter, citing increasing benefit from a higher proportion of sales generated by its self-produced high efficiency mono products and further reductions in production cost.</li><li>For Q2, JKS estimates total solar module shipments of 3.2-3.3 GW; for the full year, the company reaffirms total solar module shipment guidance of 14-15 GW.</li><li>At the end of Q1, JKS says in-house annual silicon wafer, solar  cell and solar module production capacity was 10.5, 7 and 11 GW,  respectively; it forecasts annual silicon wafer, solar cell and solar module production  capacity to reach 15, 10 and 16 GW, respectively, by year-end 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474542\" data-linked=\"JinkoSolar Q1 module shipments jumped 50% Y/Y, topping guidance\" data-tweet=\"$JKS - JinkoSolar Q1 module shipments jumped 50% Y/Y, topping guidance https://seekingalpha.com/news/3474542-jinkosolar-q1-module-shipments-jumped-50-y-y-topping-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3474542-jinkosolar-q1-module-shipments-jumped-50-y-y-topping-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474541\" data-ts=\"1561721664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474541-constellation-brands-eps-beats-0_15-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Constellation Brands EPS beats by $0.15, beats on revenue</a></h4><ul><li>Constellation Brands (NYSE:<a href='https://seekingalpha.com/symbol/STZ' title='Constellation Brands, Inc.'>STZ</a>): Q1 Non-GAAP EPS of $2.21 <font color=\"green\">beats by $0.15</font>; GAAP EPS of -$1.30.</li><li>Revenue of $2.1B (+2.4% Y/Y) <font color=\"green\">beats by $30M</font>.</li><li>Shares <font color=\"green\">+5.95%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17559027-constellation-brands-reports-first-quarter-fiscal-2020-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3474541\" data-linked=\"Constellation Brands EPS beats by $0.15, beats on revenue\" data-tweet=\"$STZ $STZ.B - Constellation Brands EPS beats by $0.15, beats on revenue https://seekingalpha.com/news/3474541-constellation-brands-eps-beats-0_15-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3474541-constellation-brands-eps-beats-0_15-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474539\" data-ts=\"1561721265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QLYS\" target=\"_blank\">QLYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474539-qualys-gains-on-nomuras-buy-start\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualys gains on Nomura&#39;s Buy start</a></h4><ul><li>Nomura starts Qualys (NASDAQ:<a href='https://seekingalpha.com/symbol/QLYS' title='Qualys, Inc.'>QLYS</a>) with a Buy rating and a $108 price target, a 26% upside.</li><li>Qualys shares are <font color=\"green\">up 0.7%</font> pre-market to $86.07.</li><li>QLYS has an Outperform average <a href=\"https://seekingalpha.com/symbol/QLYS/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474539\" data-linked=\"Qualys gains on Nomura&#39;s Buy start\" data-tweet=\"$QLYS - Qualys gains on Nomura&#39;s Buy start https://seekingalpha.com/news/3474539-qualys-gains-on-nomuras-buy-start?source=tweet\" data-url=\"https://seekingalpha.com/news/3474539-qualys-gains-on-nomuras-buy-start\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474535\" data-ts=\"1561720846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCM\" target=\"_blank\">HCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474535-chi-med-prices-upsized-ads-offering-shares-down-11-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chi-Med prices upsized ADS offering; shares down 11% premarket</a></h4><ul> <li>Hutchison China MediTech (NASDAQ:<a href='https://seekingalpha.com/symbol/HCM' title='Hutchison China MediTech Limited'>HCM</a>) has <a href=\"https://seekingalpha.com/pr/17558938-chi-med-announces-pricing-upsized-u-s-public-secondary-offering-american-depositary-shares\" target=\"_blank\">priced</a> its upsized public secondary offering of 12M ADS, at $24/ADS.</li>     <li>Underwriters over-allotment is an additional 1.8M ADSs.</li><li>Closing date is July 2.</li><li>Shares are down <font color=\"red\">11%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3474501-chi-med-announces-secondary-offering-shares-11-percent\" target=\"_blank\">Chi-Med announces secondary offering; shares down 11%</a> (June 27)</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3474535\" data-linked=\"Chi-Med prices upsized ADS offering; shares down 11% premarket\" data-tweet=\"$HCM - Chi-Med prices upsized ADS offering; shares down 11% premarket https://seekingalpha.com/news/3474535-chi-med-prices-upsized-ads-offering-shares-down-11-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3474535-chi-med-prices-upsized-ads-offering-shares-down-11-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474534\" data-ts=\"1561720510\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PG\" target=\"_blank\">PG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474534-procter-gamble-gains-after-goldman-sachs-lift\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Procter &amp; Gamble gains after Goldman Sachs lift</a></h4><ul> <li>Goldman Sachs turns bullish on Procter &amp; Gamble (NYSE:<a href='https://seekingalpha.com/symbol/PG' title='The Procter & Gamble Company'>PG</a>) as it forecasts organic volume and profit dollar growth for the consumer products giant in 12 of the next 13 quarters.</li> <li>\"We believe there is a role in investors\u2019 portfolios for a large liquid global staples company such as this and note that PG remains the most underweight US listed mega-cap global consumer packaged goods company among mutual funds,\" reads the Goldman note.</li> <li>GS lifts Procter &amp; Gamble to a Buy rating from Neutral and hikes its price target to $125 from $114. The sell-side community has a consensus Outperform rating on P&amp;G and PT of $107.91, while the <a href=\"https://seekingalpha.com/symbol/PG/ratings/quant-ratings\" target=\"_blank\">Seeking Alpha Quant Rating</a> is Neutral.</li> <li>Shares of P&amp;G are <font color=\"green\">up 1.31%</font> premarket to $111.22.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474534\" data-linked=\"Procter &amp; Gamble gains after Goldman Sachs lift\" data-tweet=\"$PG - Procter &amp; Gamble gains after Goldman Sachs lift https://seekingalpha.com/news/3474534-procter-gamble-gains-after-goldman-sachs-lift?source=tweet\" data-url=\"https://seekingalpha.com/news/3474534-procter-gamble-gains-after-goldman-sachs-lift\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474533\" data-ts=\"1561720367\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTCT\" target=\"_blank\">PTCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474533-european-advisory-group-rejects-extended-use-of-ptcs-translarna-shares-down-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European advisory group rejects extended use of PTC&#39;s Translarna; shares down 7% premarket</a></h4><ul><li>PTC Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics, Inc.'>PTCT</a>) is down <font color=\"red\">7%</font> premarket on light volume in reaction to a <a href=\"https://seekingalpha.com/pr/17558972-ptc-provides-update-translarna-ataluren-application-label-expansion\" target=\"_blank\">negative opinion</a> from the European Medicines Agency's advisory group CHMP against approval for Translarna (ataluren) for non-ambulatory patients with nonsense mutation Duchenne muscular dystrophy &#40;DMD&#41;.</li><li>Translarna is currently approved in the EU for ambulatory DMD patients over the age of two.</li><li>The company plans to request a re-examination.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474533\" data-linked=\"European advisory group rejects extended use of PTC&#39;s Translarna; shares down 7% premarket\" data-tweet=\"$PTCT - European advisory group rejects extended use of PTC&#39;s Translarna; shares down 7% premarket https://seekingalpha.com/news/3474533-european-advisory-group-rejects-extended-use-of-ptcs-translarna-shares-down-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3474533-european-advisory-group-rejects-extended-use-of-ptcs-translarna-shares-down-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474525\" data-ts=\"1561719318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRNE\" target=\"_blank\">SRNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474525-sorrento-therapeutics-launches-equity-offering-shares-down-17-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sorrento Therapeutics launches equity offering; shares down 17% premarket</a></h4><ul> <li>Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) <a href=\"https://seekingalpha.com/pr/17558955-sorrento-therapeutics-announces-proposed-public-offering-common-stock-warrants\" target=\"_blank\">intends</a> to offer and sell, shares of its common stock and Series A, Series B and Series C warrants to purchase common shares in a public offering.</li><li>Underwriters over-allotment is an additional 15% of common shares and/or warrant combinations.</li><li>Net proceeds will be used for clinical development of its RTX, CEA CAR-T and CD38 CAR-T programs, working capital and general corporate purposes.</li><li>Prices, volumes and terms have yet to be announced.</li><li>Shares are down <font color=\"red\">17%</font> premarket.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3474525\" data-linked=\"Sorrento Therapeutics launches equity offering; shares down 17% premarket\" data-tweet=\"$SRNE - Sorrento Therapeutics launches equity offering; shares down 17% premarket https://seekingalpha.com/news/3474525-sorrento-therapeutics-launches-equity-offering-shares-down-17-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3474525-sorrento-therapeutics-launches-equity-offering-shares-down-17-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474520\" data-ts=\"1561717925\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALNA\" target=\"_blank\">ALNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474520-allena-pharma-secures-10m-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allena Pharma secures $10M capital raise</a></h4><ul> <li>Allena Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ALNA' title='Allena Pharmaceuticals, Inc.'>ALNA</a>) has <a href=\"https://seekingalpha.com/pr/17558846-allena-pharmaceuticals-announces-10_0-million-registered-direct-offering-common-stock\" target=\"_blank\">entered</a> into a securities purchase agreement for the purchase and sale of 2,632,092 common shares, at a price of $3.80/share, in a registered direct offering, for gross proceeds of ~$10M.</li><li>Closing date is June 28.</li>   <li>Net proceeds will be used to fund clinical development programs, working capital and other general corporate purposes.</li><li>Shares are down <font color=\"red\">2%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3474520\" data-linked=\"Allena Pharma secures $10M capital raise\" data-tweet=\"$ALNA - Allena Pharma secures $10M capital raise https://seekingalpha.com/news/3474520-allena-pharma-secures-10m-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3474520-allena-pharma-secures-10m-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474514\" data-ts=\"1561715699\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JKS\" target=\"_blank\">JKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474514-jinkosolar-holding-eps-beats-0_02-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JinkoSolar Holding EPS beats by $0.02, misses on revenue</a></h4><ul><li>JinkoSolar Holding (NYSE:<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>): Q1 Non-GAAP EPADS of $0.12 <font color=\"green\">beats by $0.02</font>; GAAP EPADS of $0.15.</li><li>Revenue of $867.51M <font color=\"red\">misses by $27.89M</font>.</li><li>Shares <font color=\"green\">+1.89%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17558933-jinkosolar-announces-first-quarter-2019-financial-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3474514\" data-linked=\"JinkoSolar Holding EPS beats by $0.02, misses on revenue\" data-tweet=\"$JKS - JinkoSolar Holding EPS beats by $0.02, misses on revenue https://seekingalpha.com/news/3474514-jinkosolar-holding-eps-beats-0_02-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3474514-jinkosolar-holding-eps-beats-0_02-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":63,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}